Cephalon, Inc.

  CEPH 72.32 +1.30 (+1.8%)

Cephalon discovers, develops, and markets products which treat human diseases. The company focuses on 4 main segments: central nervous system disorders, pain problems, cancer, and addiction problems.

What do YOU think?

Use the icons below to select how you think CEPH will perform over the next 90 days. Just like you'd suspect, red is bad and green is good.

    Sentiment
  • Spc

    Sentiment

  • Very Low

    Activity

Have something to say?

Register for Piqqem
and give us your take on Cephalon, Inc.